| Stage | AMKR | % of rev | ENS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.0B | 100.00% | $936M | 100.00% | AMKR ×2.13 |
| Gross profit | $364M | 18.26% | $313M | 33.49% | ENS +15.2pp |
| Operating income | $225M | 11.29% | $151M | 16.18% | ENS +4.9pp |
| Pre-tax income | $230M | 11.56% | $135M | 14.43% | ENS +2.9pp |
| Net income | $191M | 9.59% | $116M | 12.45% | ENS +2.9pp |
| Stage | AMKR | ENS | Gap · A − B |
|---|---|---|---|
| Revenue | $2.0B100.00% | $936M100.00% | AMKR ×2.13 |
| Gross profit | 18.26%$364M | 33.49%$313M | ENS +15.2pp |
| Operating income | 11.29%$225M | 16.18%$151M | ENS +4.9pp |
| Pre-tax income | 11.56%$230M | 14.43%$135M | ENS +2.9pp |
| Net income |
| 9.59%$191M |
| 12.45%$116M |
| ENS +2.9pp |
No shared counterparties.